Pit Lane to Patient Bay: What Formula One Teaches Life Sciences

A children’s hospital cut surgical handover errors by more than 40% after its doctors studied a Ferrari pit crew, new research has found that the cooling shirt Formula One has just made mandatory for hot races actually raises a driver’s physiological strain rather than lowering it, and an analysis of seventy-three years of Formula One crashes has quantified exactly how much safer the sport has become since the Halo device arrived. None of these findings came from a hospital ward built for the purpose. They came from studying, and sometimes correcting, the world of motor racing.

Formula One is an unusually productive place to study human performance under stress, because it combines extreme physical loads, split-second teamwork and meticulous data collection in a way few other environments can replicate outside a laboratory. Three pieces of research and practice from recent years show what happens when life sciences takes that environment seriously, whether by copying it, testing it, or measuring what it actually costs the human body.

The Pit Stop That Rewired a Children’s Hospital

In the early 2000s, staff at Great Ormond Street Hospital in London were struggling with a specific, dangerous problem: patient handovers from the operating theatre to intensive care were error-prone, with one internal study finding that roughly 70% of avoidable mistakes at the hospital happened during precisely this handover. Surgeon Martin Elliott and colleague Allan Goldman, struck by the speed and precision of a Formula One pit stop they watched on television, contacted McLaren and travelled to Ferrari’s headquarters in Maranello to study how pit crews worked. When they showed Ferrari’s technical director footage of their own patient handovers, the verdict was blunt: no defined hierarchy, no order to how equipment was connected and disconnected, several important conversations happening at once, exactly the chaos a well-drilled pit crew is trained to eliminate. Ferrari’s pit stops, by contrast, ran on defined roles, a designated team leader, and repetitive rehearsal. Elliott and Goldman built a four-phase handover protocol around those principles, covering preparation, patient transfer, structured information handover and forward planning for complications. Published in Paediatric Anaesthesia, the results were substantial: handover errors fell from 5.4 to 3.1 per case, and information omissions fell from 2.1 to 1.1, with the protocol simple enough to teach in a 15 to 30 minute training session. The approach has since been adapted well beyond one paediatric ICU, and it remains one of the clearest examples of a medical safety process built by directly copying a pit lane rather than reinventing one from scratch.

The Cooling Shirt That Doesn’t Cool

The second story is a genuinely current piece of exercise physiology, and it complicates rather than confirms what motorsport assumed it already knew. As Formula One has confronted a run of high-heat races, cockpit air temperatures have been recorded as high as the mid-60s Celsius, the FIA has made cooling vests mandatory for the 2026 season at high-heat events, unless a team accepts a five-kilogram weight penalty instead. Research led by Associate Professor David Ferguson at Michigan State University, published in the March 2026 issue of Medicine & Science in Sports & Exercise, tested exactly how well the standard equipment works. Fourteen elite-level racing drivers completed six separate one-hour cycling trials at 65 to 75% of maximum heart rate in a hot, humid environment while wearing FIA-approved racing suits, each trial testing a different cooling method. The result for the industry-standard Cool Shirt, a water-circulating garment worn under the fire suit, was counterintuitive: after 30 minutes it produced the highest physiological strain index of any condition tested, including no cooling at all, and while it did lower skin temperature, it failed to reduce core body temperature by the end of the trial. The methods that actually worked, cold air blown into the suit or helmet, kept both skin and core temperature lowest of all six conditions. It is exactly the kind of finding that only emerges when a piece of safety equipment already in wide use gets tested properly rather than assumed to work, and it has direct relevance well beyond racing, for anyone managing heat stress in protective clothing, from industrial workers to military personnel.

Seventy-Three Years of Crashes, Measured

The third piece of research turns the sport’s own history into a long-running clinical dataset. Published in JAAOS Global Research & Reviews in May 2025, a team led by researchers at Northwell Health reviewed public records for 865 Formula One drivers across the sport’s full history, from 1950 to 2023, cataloguing 264 injuries and 43 deaths. The trend was a steady decline in total injuries, deaths and fractures over that period, tracking closely against a sequence of specific safety interventions: mandatory helmets from 1952, carbon-fibre helmets from 2001, head-and-neck support devices, known as HANS, from 2003, and the Halo cockpit protection device from 2018. Head and neck injuries had been the leading cause of death in the sport before 2001, and the study found drivers who suffered head or neck injuries were less likely to return to racing at all afterwards, underlining how much of the sport’s safety history is really a history of protecting the skull and cervical spine specifically. Separate FIA simulations of 40 historical accidents, run to assess the Halo’s introduction, estimated it improved survival odds by 17% in scenarios where it was tested. The Halo is now mandatory not just in Formula One but in Formula 2, Formula 3, Formula 4 and Formula E, and it directly influenced IndyCar’s development of its own Aeroscreen, a rare case of one motorsport series’ injury-prevention engineering propagating almost unchanged into a rival series and into the broader biomechanics of head and neck trauma research.

A Sport That Measures Everything

What connects a children’s hospital ward, a cycling ergometer in a Michigan lab, and seventy-three years of crash records is Formula One’s obsession with measurement, of time, of temperature, of exactly what happens to a human body under load. That obsession has produced a sport safe enough that a device improving survival by 17% in a crash is treated as an incremental gain rather than a breakthrough, and disciplined enough that a hospital could copy its pit lane and cut surgical errors by nearly half. It has also, this year, produced a study willing to embarrass a piece of equipment the sport had already made mandatory. That last part matters as much as the successes: a field this closely measured cannot hide from its own data, and life sciences is one of the beneficiaries of that discipline every time it borrows from the paddock.

Sources include Paediatric Anaesthesia, JAAOS Global Research & Reviews, Michigan State University, Medicine & Science in Sports & Exercise, and the FIA.

Author

Leave A Comment

Graham Combe

Strategic Consultant,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Graham Combe is an experienced strategic consultant, relationship builder, and entrepreneur in the global life sciences sector. He holds a BSc (Hons) in Chemistry from University College London (UCL) and spent over a decade with Nature, where he pioneered key initiatives such as Nature’s BioPharma Dealmakers and Nature’s SciCafe.

In May 2011, he founded Biosell UK, a consulting and event management firm that collaborates with global life science publishers, event organizations, and marketing partners. Beyond BioSell, Combe is the founder or co-founder of several prominent networking and thought-leadership platforms, including #BiotechBuddies, #coffeebuddies, the #AgileLeaders Forum, and the Creative Disruption Forum—the latter three events co-hosted with his business partner, Professor Tony Sedgwick.

Specializing in the early-to-mid stages of drug development (from pre-clinical research through Phase 3 and clinical proof-of-concept), Graham focuses on facilitating forums to promote peer-to-peer discussion, strategic growth, investment and meaningful connections between biotech innovators, investors, and industry service providers.

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details